Angiotensin II - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:58:35Z

Switch SMW query from broadtable to table format for better layout with TOC

← Revisión anterior		Revisión del 21:58 20 mar 2026
Línea 60:		Línea 60:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T17:26:46Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

← Revisión anterior		Revisión del 17:26 20 mar 2026
Línea 62:		Línea 62:
	\|format=broadtable		\|format=broadtable
	\|headers=plain		\|headers=plain
	\|~~link~~=~~subject~~		\|mainlabel=-
	\|sort=Has Indication		\|sort=Has Indication
	\|limit=50		\|limit=50

Danbot: Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

2026-03-20T16:45:04Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

@@ Línea 49: / Línea 49: @@
 *Patient's on ACEi may have increased response to Angiotensin II
 *Patient's on ARB's may have decreased response to Angiotensin II
 ==See Also==

Masoodrm: /* Mechanism of Action */

2021-06-16T17:20:36Z

Mechanism of Action

← Revisión anterior		Revisión del 17:20 16 jun 2021
Línea 44:		Línea 44:
	==Mechanism of Action==		==Mechanism of Action==
	*Synthetic human angiotensin II which is a peptide hormone of the renin-angiotensin-aldosterone system (RAAS) that causes vasoconstriction and an increase in blood pressure		*Synthetic human angiotensin II which is a peptide hormone of the renin-angiotensin-aldosterone system (RAAS) that causes vasoconstriction and an increase in blood pressure
	*Increases ~~aldosterone~~		*Increases Aldosterone

	==Comments==		==Comments==

Masoodrm: /* Adverse Reactions */

2021-06-16T17:19:27Z

Adverse Reactions

← Revisión anterior		Revisión del 17:19 16 jun 2021
Línea 30:		Línea 30:
	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
	*~~Thrombotic~~ (13%		*Thrombosis (13%)
	**DVT (4%)		**[[DVT]] (4%)
	*Thrombocytopenia (9%)		*Thrombocytopenia (9%)
	*Tachycardia (8.6%)		*Tachycardia (8.6%)

SeanDenny: /* Adult Dosing */

2020-12-10T00:27:40Z

Adult Dosing

← Revisión anterior		Revisión del 00:27 10 dic 2020
Línea 6:		Línea 6:

	==Adult Dosing==		==Adult Dosing==
	Septic or Distributive Shock		Septic or Distributive [[Shock]]
	*20 nanograms (ng)/kg/min.		*20 nanograms (ng)/kg/min.
	**Titrate as frequently as every 5 minutes by increments of up to 15 ng/kg/min as needed. <br />		**Titrate as frequently as every 5 minutes by increments of up to 15 ng/kg/min as needed. <br />

ClaireLewis at 17:12, 19 September 2019

2019-09-19T17:12:22Z

← Revisión anterior		Revisión del 17:12 19 sep 2019
Línea 56:		Línea 56:
	<references/>		<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:Cardiology]]

Mrosen5506: Created page with "==Administration== Type: vasopressor Dosage Forms: Injection: 2.5 mg/mL and 5 mg/2 mL (2.5 mg/mL) in a vial Routes of Administration: IV Common Trade Names: GIAPREZA ==Ad..."

2018-08-12T03:39:48Z

Created page with "==Administration== *Type: vasopressor *Dosage Forms: Injection: 2.5 mg/mL and 5 mg/2 mL (2.5 mg/mL) in a vial *Routes of Administration: IV *Common Trade Names: GIAPREZA ==Ad..."

Página nueva

==Administration==
*Type: vasopressor
*Dosage Forms: Injection: 2.5 mg/mL and 5 mg/2 mL (2.5 mg/mL) in a vial
*Routes of Administration: IV
*Common Trade Names: GIAPREZA

==Adult Dosing==
Septic or Distributive Shock
*20 nanograms (ng)/kg/min.
**Titrate as frequently as every 5 minutes by increments of up to 15 ng/kg/min as needed. <br />
During the first 3 hours, the maximum dose should not exceed 80 ng/kg/min. <br />
Maintenance dose should not exceed 40 ng/kg/min

==Special Populations==
===[[Drug pregnancy categories|Pregnancy Rating]]===
*unkown

===Lactation risk===
*unknown

===Renal Dosing===
None

===Hepatic Dosing===
None

==Contraindications==
*Allergy to class/drug

==Adverse Reactions==
===Serious===
*Thrombotic (13%
**DVT (4%)
*Thrombocytopenia (9%)
*Tachycardia (8.6%)
*Fungal infection (6.1%)

===Common===

==Pharmacology==
*Half-life: ~1 minute
*Metabolism: broken down by proteins in blood, RBC's, major organs

==Mechanism of Action==
*Synthetic human angiotensin II which is a peptide hormone of the renin-angiotensin-aldosterone system (RAAS) that causes vasoconstriction and an increase in blood pressure
*Increases aldosterone

==Comments==
*Patient's on ACEi may have increased response to Angiotensin II
*Patient's on ARB's may have decreased response to Angiotensin II

==See Also==
*[[Sepsis (Main)]]

==References==
<references/>

[[Category:Pharmacology]]